Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Int J Androl. 2012 May 29;35(6):775–782. doi: 10.1111/j.1365-2605.2012.01285.x

Table 1.

Baseline characteristics of the study population with complete 10-year follow-up.*

Characteristic
Age, years 71.2 ± 6.4
Body Mass Index, kg/m2 26.6 ± 3.8
Current Smoker, % 16.5
Systolic Blood Pressure, mmHg 141.6 ± 18.5
Diastolic Blood Pressure, mmHg 78.0 ± 10.0
Antihypertensive Medication, % 41.2
Hypertension, % 68.4
Type 2 Diabetes, % 12.7
HDL Cholesterol, mg/dl 44.3 ± 13.6
Total Cholesterol, mg/dl 216.6 ± 37.4
Ratio Total : HDL Cholesterol, mg/dl 5.3 ± 1.6
Prevalence of Cardiovascular Disease, % 34.3
Total Testosterone, ng/ml 4.9 (3.9; 5.9)
DHEAS, mg/dl 91.2 (56.8; 137.0)
FSH, IU/l 9.0 (6.2; 13.4)
Luteinizing Hormone, IU/l 8.6 (6.2; 12.0)
Total Estradiol, pg/ml 30.2 (21.3; 39.2)

Data are percentages, mean ± SD, or median (Q1; Q3).

*

Baseline characteristics are presented for the sample with the largest available data for sex steroids and gonadotropins: total testosterone, N = 834; dehydroepiandrosterone sulfate (DHEAS), N = 657, follicle stimulating hormone (FSH), N = 835, luteinizing hormone, N = 835; estradiol, N = 834. Values for these hormones are reported based on availability of each hormone.